Company: BSX
Filing Date: 2025-03-19
Form Type: DEF 14A
Source: 0000885725-25-000017
Chunk: 56

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-03-19
Form: DEF 14A
Chunk 56
---
 Operating Income        
 Margin(1)(2)for ABP     |     | 16.4%                                                           
 Organic Net Sales Growth(1)(2)versus 2023, for 2024 ONSG PSP(3) |
|                           |     | 115.86%                         
 3-year rTSR(4)For 2022 rTSR PSP |     |                                                         |     |                         |     |                                                                 |

(1) Adjusted Net Sales, Adjusted EPS, Adjusted OIM and ONSG are non-GAAP financial measures. For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures and insight into how these non-GAAP financial measures are considered by management, please see Annex A to this Proxy Statement.

(2) As used in the 2024 ABP, (i) Adjusted Net Sales excludes foreign currency fluctuations and the impact of net sales from acquisitions completed after the establishment of the internal financial plan, as applicable, (ii) Adjusted EPS excludes the impact of certain charges (credits) which may include amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), investment portfolio net losses (gains) and impairments, restructuring and restructuring-related net charges (credits), and certain litigation-related net charges (credits), European Union (EU) Medical Device Regulation (MDR) implementation costs, debt extinguishment net charges, deferred tax expenses (benefits) and discrete tax items and (iii) Adjusted OIM reflects the Company’s adjusted operating income (GAAP revenue less cost of goods sold less operating expenses, adjusted for certain items consistent with those excluded to determine Adjusted EPS) as a percentage of net sales. ONSG excludes the impact of foreign currency fluctuations and acquisitions and divestitures for which there is less than a full period of comparable net sales.

(3) 2024 ONSG PSP has a three-year performance period, comparing actual ONSG performance against our financial plan for the period from January 1, 2024 to December 31, 2026.

(4) Three-year TSR for the period from January 1, 2022 to December 31, 2024. Please see 2024 relative Total Shareholder Return Performance Share Program on pa ge 77 for how we calculate TSR.

We maintain a disciplined approach to management of our incentive compensation programs. We set ambitious but achievable program targets, taking into consideration relevant, foreseeable